CB
Cue Biopharma
🇩🇪XFRA.1UCGermanyHealthcare
€24.08EURup +1.42 (+6.27%)OpenEnd of day8:26 AM
Price€24.08+1.42 (+6.27%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US22978P1066
- CUSIP
- Not reported
Company
- Employees
- 29
- Headquarters
- Boston, United States
- Website
- https://www.cuebiopharma.com
- CEO
- Dr. Shao-Lee Lin M.D., Ph.D.
Market
- Shares outstanding
- 3.3M
- Market cap
- €78.39M
Highlights
- Market cap
- €78.39M
- EPS LTM
- -$25.88
- P/E LTM
- -1.28
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $37.65M+354.37%up year on year
- Net income
- -$164.11M-321.93%down year on year
- Gross margin
- 90.98%-6.83%down year on year
- Free cash flow
- -$50.17M-77.14%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.